Insulin-loaded poly(acrylic acid)-cysteine nanoparticles: Stability studies towards digestive enzymes of the intestine Insulin-loaded poly(acrylic acid)-cysteine nanoparticles Glen Perera et al.

Drug Delivery

Volumn 16, Issue 5, 2009, Pages 254-260

  Perera, Glen ^a   Greindl, Melanie ^a   Palmberger, Thomas F ^a   Bernkop Schnrch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Insulin; Nanoparticles; Oral peptide delivery; Thiomers

Indexed keywords

CHYMOTRYPSIN A; CYSTEINE; ELASTASE; INSULIN; INTESTINE ENZYME; POLYACRYLIC ACID; POLYACRYLIC ACID PLUS CYSTEINE NANOPARTICLE; SERINE PROTEINASE; TRYPSIN; UNCLASSIFIED DRUG; ACRYLIC ACID; ACRYLIC ACID DERIVATIVE; ALPHA-CHYMOTRYPSIN; ANTIDIABETIC AGENT; CHYMOTRYPSIN; DRUG CARRIER; NANOPARTICLE; PANCREATIC ELASTASE;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG STABILITY; DRUG SYNTHESIS; ENZYME DEGRADATION; IN VITRO STUDY; NANOPHARMACEUTICS; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL; CHEMISTRY; ENZYMOLOGY; INTESTINE; METABOLISM; ORAL DRUG ADMINISTRATION; PHARMACEUTICS;

ACRYLATES; ADMINISTRATION, ORAL; CHYMOTRYPSIN; CYSTEINE; DRUG CARRIERS; DRUG STABILITY; HYPOGLYCEMIC AGENTS; INSULIN; INTESTINES; NANOPARTICLES; PANCREATIC ELASTASE; SERINE ENDOPEPTIDASES; TECHNOLOGY, PHARMACEUTICAL; TRYPSIN;

EID: 70349329277     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540902937471     Document Type: Article

References (28)

1. Akiyoshi, K., Kobayashi, S., Shichibe, S., Mix, D., Baudys, M., Kim, S.W., Sunamoto, J. (1998). Self-assembled hydrogel nanoparticles of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J Contr Rel. 54, 313-320
2. Bai, J.P., Chang, L.L., Guo, J.H. (1996). Effects of polyacrylic polymers on the d egradation of insulin and peptide drugs by chymotrypsin and trypsin. J Pharm Pharmacol. 48, 17-21.
3. Bernkop-Schnürch, A., Fragner, R. (1996). Investigations into the diffusion behaviour of polypeptides in native intestinal mucus with regard to their peroral administration. Pharm Sci. 2, 361-363
4. Bernkop-Schnürch, A., Walker, G. (2001). Multifunctional matrices for oral peptide delivery. Crit Rev Ther Drug Carrier Syst. 18, 459-501.
5. Bernkop-Schnürch, A., Schwarz, V., Steininger, S. (1999). Polymers with thiol groups: a new genereation of mucoadhesive polymers? Pharm Res. 16, 876-881 (Pubitemid 29284199)
6. Bernkop-Schnürch, A., Walker, G., Zarti, H. (2001). Thiolation of polycarbophil enhances its inhibition of intestinal brush border membrane bound aminopeptidase. N J Pharm Sci. 90, 1907-1914
7. Bodmeier, R., Chen, H.G., Paeratakul, O. (1989). A novel approach to the oral delivery of micro- or nanoparticles. Pharm Res. 96, 413-417
8. Coupe, A.J., Davis, S.S., Wilding, I.R. (1991). Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res. 8, 360-364
9. Cui, F.D., Tao, A.J., Cun, D.M., Zhang, L.Q., Shi, K. (2007). Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery. J Pharm Sci. 96, 421-427
10. Habeeb, A.F. (1973). A sensitive method for localization of disulfide containing peptides in column effluents. Anal Biochem. 56, 60-65
11. James, D.E., Jenkins, A.B., Kaegen, E.W., Chisholm, D.J. (1981). Insulin precipitation in artificial infusion devices. Diabetologia. 21, 554-557
12. Jintapattanakit, A., Junyaprasert, V.B., Mao, S., Sitterberg, J., Bakowsky, U., Kissel, T. (2007). Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm. 342, 240-249.
13. Kriwet, B., Walter, E., Kissel, T. (1998). Synthesis of bioadhesive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. J Contr Rel. 56, 149-158
14. Lamprecht, A., Schafer, U., Lehr, C.M. (2001). Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res. 18, 788-793
15. Marschütz, M.K., Bernkop-Schnürch, A. (2000). Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro. Biomaterials. 21, 1499-1507
16. Marschütz, M.K., Bernkop-Schnürch, A. (2002). Thiolated polymers: self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur J Pharm Sci. 15, 387-394
17. Mollmann, S.H., Elofsson, U., Bukrinsky, J.T., Frokjaer, S. (2005). Displacement of adsorbed insulin by Tween 80 monitored using internal reflection fluorescence and ellipsometry. Pharm Res. 22, 1931-1941
18. Narayanan, A.S., Anwar, R.A. (1969). The specifity of purified porcine pancreatic elastase. Biochem J. 114, 11-17.
19. Nurkeeva, Z.S., Mun, G.A., Khutoryanskiy, V.V., Bitekenova, A.B., Dubolazov, A.V., Esirkegenova, S.Z. (2003). pH effects in the formation of interpolymer complexes between poly(N- vinylpyrrolidone) and poly(acrylic acid) in aqueous solutions. Eur Phys J E Soft Mater. 10, 65-68
20. Palmberger, T.F., Albrecht, K., Loretz, B., Bernkop-Schnürch, A. (2007). Thiolated polymers: evaluation of the influence of the amount of covalently attached L-cysteine to poly(acrylic acid). Eur J Pharm Biopharm. 66, 405-412.
21. Ponchel, G., Irache, J. (1998). Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev. 34, 191-219.
22. Pusztai, A. (1989). Transport of proteins through the membranes of the adult gastro-intestinal tract-a potential for drug delivery? Adv Drug Deliv Rev. 3, 215-228
23. Sakuma, S., Ishida, Y., Sudo, R., Suzuki, N., Kikuchi, H., Hiwatari, K., Kishida, A., Akashi, M., Hayashi, M. (1997). Stabilization of salmon calcitonin by polystyrene nanoparticles having surface hydrophobic polymeric chains, against enzymatic degradation. Int J Pharm. 159, 181-189
24. Satake, K., Okuyama, T., Ohashi, M., Shinoda, T. (1960). The spectrophotometric determination of amines, amino acids and peptide with 2,4,6-trinitrobenzene-1-sulfonic acid. J Biochem. 47, 654.
25. Schilling, R.J., Mitra, A.K. (1991). Degradation of insulin by trypsin and alpha-chymotrypsin. Pharm Res. 8, 360-364
26. Stark, B., Andreae, F., Mosgoeller, W., Edetsberger, M., Gaubitzer, E., Koehler, G., Prassl, R. (2008). Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation. Eur J Pharm Biopharm. 70, 153-164
27. Werle, M., Samhaber, A., Bernkop-Schnürch, A. (2006). Degradation of teriparatide by gastro-intestinal proteolytic enzymes. J Drug Target. 14, 109-115
28. Woodley, J.F. (1994). Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst. 11, 61-95.